Beta-Blockers and ACE Inhibitors Are Associated with Improved Survival Secondary to Ventricular Tachyarrhythmia.
Tobias SchuppMichael BehnesChristel WeißChristoph NienaberSiegfried LangLinda ReiserArmin BollowGabriel TatonThomas ReicheltDominik EllguthNiko EngelkeUzair AnsariIbrahim El-BattrawyThomas BertschMuharrem AkinKambis MashayekhiMartin BorggrefeIbrahim AkinPublished in: Cardiovascular drugs and therapy (2019)
ClinicalTrials.gov identifier: NCT02982473.